Skip to main content
Clinical Cardiology logoLink to Clinical Cardiology
. 2006 Dec 5;27(6):338–342. doi: 10.1002/clc.4960270608

High remnant lipoprotein levels in patients with variant angina

Kunihisa Miwa 1,, Toshinori Makita 1, Katsuhisa Ishii 1, Nobuaki Okuda 1, Ataru Taniguchi 1
PMCID: PMC6653988  PMID: 15237693

Abstract

Background: Dyslipidemia with increased oxidative stress but without elevation of low‐density lipoprotein cholesterol has been recently implicated in the pathogenesis of coronary vasospasm.

Hypothesis: Disordered triglyceride‐rich lipoprotein metabolism may be linked to the genesis of coronary artery spasm.

Methods: Both serum remnant lipoprotein (RLP) and α‐tocopherol levels were determined in 18 patients with the active stage of variant angina (VA), in 16 patients with the inactive stage of variant angina (IVA), and in 19 control subjects (CONTROL).

Results: The RLP levels were significantly (p < 0.05) higher in VA (6.4 ± 2.7 mg/dl) than in IVA (4.4 ± 1.5 mg/dl). In contrast, α‐tocopherol levels were significantly lower in VA than that in CONTROL. Serum trigyceride levels were not significantly different among the study groups, although serum high‐density lipoprotein cholesterol levels were significantly lower in VA than in CONTROL. Smoking was significantly (p < 0.05) more prevalent in VA (72%) than in IVA (25%) and CONTROL (37%). Serum RLP levels correlated positively with triglyceride levels (R = 0.73) and correlated inversely with α‐tocopherol levels (R = ‐ 0.31) significantly in all study subjects.

Conclusions: Patients with active stage of variant angina had higher RLP levels than inactive patients with variant angina and lower α‐tocopherol levels than control subjects. Disordered triglyceride‐rich lipoprotein metabolism with increased oxidative stress appears to be linked to the activity of coronary vasospasm, suggesting a possible role in its pathogenesis.

Keywords: coronary vasospasm, variant angina, remnant lipoproteins, α‐tocopherol

Full Text

The Full Text of this article is available as a PDF (67.7 KB).

References

  • 1. Castelli WP, Garrison RJ, Wilson PWF, Abbott RD, Kalousidan S, Kannel WB: Incidence of coronary heart disease and lipoprotein cholesterol levels. The Framingham Study. J Am Med Assoc 1986; 256: 2835–2838 [PubMed] [Google Scholar]
  • 2. Frick MH, Elo O, Haapa K, Heinonen OP, Hansalma P, Helo P, Huttunen JK, Kaitaneimi P, Koskinen P, Manninen V, Maenpaa H, Malkonen M, Maittari M, Norola S, Pasternack A, Pikkarainen J, Romo M, Sjoblom T, Nikkila EA: Helsinki Heart Study: Primary prevention trial with gemfibrozil in middle‐aged men with dyslipidemia: Safety of treatment, changes in risk factors, and incidence of coronary heart disease. N Engl J Med 1987; 317: 1237–1245 [DOI] [PubMed] [Google Scholar]
  • 3. Miwa K, Fujita M, Miyagi Y, Inoue H, Sasayama S: High‐density lipoprotein cholesterol level and smoking modify the prognosis of patients with coronary vasospasm. Clin Cardiol 1995; 18: 267–272 [DOI] [PubMed] [Google Scholar]
  • 4. Miwa K, Yoshida N, Nakagawa K, Inoue H: High‐density lipoprotein particles are large in patients with variant angina. Cardiovasc Res 1998; 37: 729–737 [DOI] [PubMed] [Google Scholar]
  • 5. Miwa K, Miyagi Y, Fujita M: Susceptibility of plasma low‐density lipoprotein to cupric ion‐induced peroxidation in patients with variant angina. J Am Coll Cardiol 1995; 26: 632–638 [DOI] [PubMed] [Google Scholar]
  • 6. Miwa K, Miyagi Y, Igawa A, Nakagawa K, Inoue H: Vitamin E deficiency in variant angina. Circulation 1996; 94: 14–18 [DOI] [PubMed] [Google Scholar]
  • 7. Mead MG, Dangerfield WG: The investigation of “midband” lipoproteins using polyacrylamide gel electrophoresis. Clin Chim Acta 1974; 51: 173–182 [DOI] [PubMed] [Google Scholar]
  • 8. Miwa K, Nakagawa K, Suzuki K, Inoue H: Detection of the “midband” lipoprotein in patients with coronary artery spasm. Clin Cardiol 2001; 24: 219–224 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9. Patsch JR, Miesenblock G, Hopferwiesser T, Muhlberger V, Knapp E, Dunn JK, Gotto AM Jr, Patsch W: Relation of triglyceride metabolism and coronary artery disease: Studies in the postprandial state. Arterioscler Thromb 1992; 12: 1336–1345 [DOI] [PubMed] [Google Scholar]
  • 10. Zilversmit DB: Atherogenic nature of triglycerides, postprandial lipidemia, and triglyceride‐rich remnant lipoproteins. Clin Chem 1995; 41: 53–58 [PubMed] [Google Scholar]
  • 11. Doi H, Kugiyama K, Ohgushi M, Sugiyama S, Matsuyama T, Ohta Y, Nakano T, Nakajima K, Yasue H: Remnants of chyromicron and very low density lipoprotein impair endothelium‐dependent vasorelaxation. Atherosclerosis 1998; 137: 341–349 [DOI] [PubMed] [Google Scholar]
  • 12. Kugiyama K, Doi H, Motoyama T, Soejima H, Misumi K, Kawano H, Nakagawa O, Yoshimura M, Ogawa H, Matsuyama T, Sugiyama S, Nakano T, Nakajima K, Yasue H: Association of remnant lipoprotein levels with impairment of endothelium‐dependent vasomotor function in human coronary arteries. Circulation 1998; 97: 2519–2526 [DOI] [PubMed] [Google Scholar]
  • 13. Kugiyama K, Motoyama T, Doi H, Kawano H, Hirai N, Soejima H, Miyao Y, Takazoe K, Moriyama Y, Mizuno Y, Tsunoda R, Ogawa H, Sakamoto T, Sugiyama S, Yasue H: Improvement of endothelial vasomotor dysfunction by treatment with alpha‐tocopherol in patients with high remnant lipoprotein levels. J Am Coll Cardiol 1999; 33: 1512–1518 [DOI] [PubMed] [Google Scholar]
  • 14. Miwa K, Fujita M, Ejiri M, Sasayama S: Comparative sensitivity of intra‐coronary injection of acetylcholine for the induction of coronary spasm in patients with various types of angina pectoris. Am Heart J 1990; 120: 544–550 [DOI] [PubMed] [Google Scholar]
  • 15. Friedwald WT, Levy RI, Frederickson DS: Estimation of the concentration of low‐density lipoprotein cholesterol in plasma without use of the preparative ultracentrifuge. Clin Chem 1972; 18: 499–508 [PubMed] [Google Scholar]
  • 16. WHO Expert Committee in Diabetes Mellitus : Second report. WHO Tech Rep Ser 1980; 646: 1–80 [PubMed] [Google Scholar]
  • 17. Fazio S, Lee Y‐L, Ji Z‐S, Rall SC Jr: Type III hyperlipoproteinemic phenotype in transgenic mice expressing dysfunctional apolipoprotein E. J Clin Invest 1993; 92: 1497–1503 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 18. Patsch JR, Gotto AM, Olivecrona T, Eisenberg S: Formation of high‐density lipoprotein2‐like particles during lipolysis of very low density lipoproteins in vitro. Proc Natl Acad Sci USA 1978; 75: 4519–4523 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 19. Hodis HN: Triglyceride‐rich lipoprotein remnant particles and risk of atherosclerosis. Circulation 1999; 99: 2852–2854 [DOI] [PubMed] [Google Scholar]
  • 20. Inoue T, Saniabadi AR, Matsunaga R, Hoshi K, Yaguchi I, Morooka S: Impaired endothelium‐dependent acetylcholine‐induced coronary artery relaxation in patients with high serum remnant lipoprotein particles. Atherosclerosis 1998; 139: 363–367 [DOI] [PubMed] [Google Scholar]
  • 21. Doi H, Kugiyama K, Oka H, Sugiyama S, Ogata N, Koide S, Nakamura S, Yasue H: Remnant lipoproteins induce proatherothrombogenic molecules in endothelial cells through a redox‐sensitive mechanism. Circulation 2000; 102: 670–676 [DOI] [PubMed] [Google Scholar]
  • 22. Tatami R, Mabuchi H, Ueda K, Ueda R, Haba T, Kametani T, Ito S, Koizumi J, Ohta M, Miyamoto S, Nakayama A, Kanaya H, Oiwake H, Genda A, Takeda R: Intermediate‐density lipoprotein and cholesterol‐rich very low density lipoprotein in angiographically determined coronary artery disease. Circulation 1981; 64: 1174–1184 [DOI] [PubMed] [Google Scholar]
  • 23. Steiner G, Schwartz L, Shumak S, Poapst M: The association of increased levels of intermediate‐density lipoproteins with smoking and with coronary artery disease. Circulation 1987; 75: 124–130 [DOI] [PubMed] [Google Scholar]
  • 24. Topping DL, Dwyer T, Weller RA: Peripheral vascular disease in cigarette smokers and impaired hepatic metabolism of lipoprotein remnants. Lancet 1977; 2: 1327–1328 [DOI] [PubMed] [Google Scholar]
  • 25. Sugiishi M, Takatsu F: Cigarette smoking is a major risk factor for coronary spasm. Circulation 1993; 87: 76–79 [DOI] [PubMed] [Google Scholar]
  • 26. Shinozaki K, Suzuki M, Ikebuchi M, Tasaki H, Hara Y, Tsushima M, Harano Y: Insulin resistance associated with compensatory hyperinsulinemia as an independent risk factor for vasospastic angina. Circulation 1995; 92: 1749–1757 [DOI] [PubMed] [Google Scholar]
  • 27. Taniguchi A, Fukushima M, Sakai M, Miwa K, Makita T, Nagata I, Nagasaka S, Doi K, Okumura T, Fukuda A, Kishimoto H, Fukuda T, Nakaishi S, Tokuyama K, Nakai Y: Remnant‐like particle cholesterol, triglycerides, and insulin resistance in nonobese Japanese type 2 diabetic patients. Diabetes Care 2000; 23: 1766–1769 [DOI] [PubMed] [Google Scholar]
  • 28. Sakata K, Miho N, Shirotani M, Yoshida H, Takada Y, Takada A: Remnantlike particle cholesterol is a major risk factor for myocardial infarction in vasospastic angina with nearly normal coronary artery. Atherosclerosis 1998; 136: 225–231 [DOI] [PubMed] [Google Scholar]
  • 29. Kugiyama K, Yasue H, Okumura K, Ogawa H, Fujimoto K, Nakao K, Yoshimura M, Motoyama T, Inobe Y, Kawano H: Nitric oxide activity is deficient in spasm arteries of patients with coronary spastic angina. Circulation 1996; 94: 266–272 [DOI] [PubMed] [Google Scholar]
  • 30. Liao JK, Clark SL: Regulation of G‐protein and ai2 subunit expression by oxidized low‐density lipoprotein. J Clin Invest 1995; 95: 1457–1463 [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Clinical Cardiology are provided here courtesy of Wiley

RESOURCES